Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/118189
Full metadata record
DC FieldValueLanguage
dc.creatorCecílio, P-
dc.creatorPérez-Cabezas, B-
dc.creatorSantarém, N-
dc.creatorMaciel, J-
dc.creatorRodrigues, V-
dc.creatorCordeiro-da-Silva, A-
dc.date.accessioned2019-01-08T09:55:03Z-
dc.date.available2019-01-08T09:55:03Z-
dc.date.issued2014-
dc.identifier.issn1664-3224-
dc.identifier.urihttps://repositorio-aberto.up.pt/handle/10216/118189-
dc.description.abstractLeishmania spp. are intracellular parasitic protozoa responsible for a group of neglected tropical diseases, endemic in 98 countries around the world, called leishmaniasis. These parasites have a complex digenetic life cycle requiring a susceptible vertebrate host and a permissive insect vector, which allow their transmission. The clinical manifestations associated with leishmaniasis depend on complex interactions between the parasite and the host immune system. Consequently, leishmaniasis can be manifested as a self-healing cutaneous affliction or a visceral pathology, being the last one fatal in 85-90% of untreated cases. As a result of a long host-parasite co-evolutionary process, Leishmania spp. developed different immunomodulatory strategies that are essential for the establishment of infection. Only through deception and manipulation of the immune system, Leishmania spp. can complete its life cycle and survive. The understanding of the mechanisms associated with immune evasion and disease progression is essential for the development of novel therapies and vaccine approaches. Here, we revise how the parasite manipulates cell death and immune responses to survive and thrive in the shadow of the immune system.-
dc.description.sponsorshipThis work was funded by FEDER funds through the Opera- tional Competitiveness Programme – COMPETE and by National Funds through FCT – Fundação para a Ciência e a Tecnologia under the project FCOMP-01-0124-FEDER-019648 (PTDC/BIA- MIC/118644/2010). Pedro Cecílio, Begoña Pérez-Cabezas, and Nuno Santarem are supported by fellowships from the European Community’s Seventh Framework Programme under grant agree- ments No. 603181 (Project MuLeVaClin), No. 603240-2 (Project NMTryPI), and No. 602773 (Project KINDRED), respectively. Joana Maciel is supported by a post-doctoral fellowship from the FCT project grant No. PTDC/BIA-MIC/118644/2010. Vasco Rodrigues is supported by a doctoral fellowship from FCT code SFRH/BD/64064/2009. The funders had no role in study design, data collection, and analysis, decision to publish, or prepara- tion of the manuscript. The authors would like to acknowledge COST Action BM1202: European Network on Microvesicles and Exosomes in Health and Disease (Me-HaD).-
dc.language.isoeng-
dc.publisherFrontiers Media-
dc.relationinfo:eu-repo/grantAgreement/FCT/COMPETE/118644/PT-
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F64064%2F2009/PT-
dc.relation.ispartofFrontiers in Immunology, vol.5: 480-
dc.rightsopenAccess-
dc.subjectLeishmania-
dc.subjectAcquired Immunity-
dc.subjectApoptosis-
dc.subjectImmunomodulation-
dc.subjectInnate Immunity-
dc.titleDeception and manipulation: The arms of Leishmania, a successful parasite-
dc.typeArtigo em Revista Científica Internacional-
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde-
dc.identifier.doi10.3389/fimmu.2014.00480-
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fimmu.2014.00480/full-
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
Cecilio_Frontiers in Immunology_2014.pdf702.11 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.